Cargando…
Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells
Taxanes represent some of the most commonly used chemotherapeutic agents for ovarian cancer treatment. However, they are only effective in approximately 40% of patients. Novel therapeutic strategies are required to potentiate their effect and improve patient outcome. A hallmark of many cancers is th...
Autores principales: | Taylor, Charlotte, Mannion, David, Mirand a, Fabrizio, Karaminejadranjbar, Mohammad, Herrero-Gonzalez, Sandra, Hellner, Karin, Zheng, Yiyan, Bartholomeusz, Geoffrey, Bast, Robert C., Ahmed, Ahmed Ashour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392300/ https://www.ncbi.nlm.nih.gov/pubmed/28152500 http://dx.doi.org/10.18632/oncotarget.14910 |
Ejemplares similares
-
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2011) -
Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022) -
High-frequency ultrasound analysis of post-mitotic arrest cell death
por: Pasternak, Maurice M., et al.
Publicado: (2016) -
Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest
por: Russell, P, et al.
Publicado: (2012) -
Mitotic arrest affects clustering of tumor cells
por: Bonnet, Julia, et al.
Publicado: (2021)